Chemotherapy and radiation are common treatments for ovarian cancer. Patients may be faced with several side effects brought about chemotherapy and radiation. However, ovarian cancer may be treated with a minimally invasive surgical option, which uses advanced technology, known as the da Vinci surgical robotic system. During robotic surgery, a few tiny incisions are required while giving an enhanced vision, precision, and control for the surgeon and allowing the patients to recover faster, move on to additional treatments if needed, and resume with their daily activities.
Nowadays, da Vinci surgical robot is the biggest thing in the operating rooms in the US hospitals. The da Vinci is equipped with advanced technologies, such as the 3-D high definition vision and miniaturized, wristed surgical instruments which able the surgeon to perform surgery beyond the limits of the human hand. Da Vinci helps the doctors to conquer the defiance of traditional open and laparascopic procedures, thus changing the experience of surgery for women around the world.
A minimally invasive procedure is permitted by da Vinci robotic surgery for ovarian problems. As a trained da Vinci robotics surgeon, your doctor can use this robotic technique to conduct surgery or even remove an ovary or ovaries; thereby resulting in a significantly better patient experience. Potential risks related to the surgical robot has provoke health experts to worry.
Because of the problems caused by da Vinci, lawsuits have been filed against the company. Patients who are planning to undergo da Vinci robotic surgery should consult the doctor to know if da Vinci is right for you according to your particular needs, says FDA. The page on da Vinci lawsuit offers a more complete information regarding this matter.
References:
cancercenter.com/ovarian-cancer/da-vinci-surgical-system/
cpmc.org/services/surgery/robotic/procedures/ovarian-cystectomy.html
fccc.edu/cancer/types/gynecological/
robotic-surgery.med.nyu.edu/for-patients/our-departments/gynecology/conditions/early-stage-ovarian-cancer
